{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T20:48:18Z","timestamp":1765831698353,"version":"3.48.0"},"reference-count":32,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T00:00:00Z","timestamp":1675900800000},"content-version":"unspecified","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science & Technology Commission","doi-asserted-by":"crossref","award":["Z191100007619054"],"award-info":[{"award-number":["Z191100007619054"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"crossref"}]},{"name":"FibroGen China","award":["no award\/grant number"],"award-info":[{"award-number":["no award\/grant number"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2022,12,16]]},"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Roxadustat is a first-in-class oral therapy that treats chronic kidney disease (CKD) anaemia with the benefit of a novel mechanism of action that consistently corrects and maintains haemoglobin (Hb) across the spectrum of non-dialysis-dependent (NDD) CKD anaemia with an acceptable safety profile.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This is a randomised, control, open-label, multicentre trial. About 250 adult Chinese participants with stage 3\u20135 CKD NDD in approximately 30 centres will be enrolled, randomly assigned in a 1:1 ratio, to receive a 16-week treatment and 4-week follow-up. The interventions for study arm are &lt;60 kg: 50\u2009mg TIW and \u226560\u2009kg: 70\u2009mg TIW; for control arm, &lt;60 kg: 70\u2009mg TIW and \u226560\u2009kg: 100\u2009mg TIW. The primary endpoint is the mean change in haemoglobin level from baseline to average over weeks 12\u201316. Secondary endpoints are to assess the proportion of subjects achieving an average Hb level of 100 to 120\u2009g\/L over weeks 12\u201316, the Hb variability, the rescue therapy requirement between two groups and the safety in two groups. The exploratory objectives are expected to evaluate the rate and time of Hb response, times of dose adjustment, the proportion of subjects with rapid Hb rise, overshooting during the treatment between two different starting dose groups, and subgroup analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The Medical Ethics Committee of Chinese PLA General Hospital has approved this study (No. S2020-523-05) and will be performed in accordance with the Declaration of Helsinki. Participant consent will be obtained in writing. Results will be disseminated via peer-reviewed publications and conference presentations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>ChiCTR2100045359.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2022-068864","type":"journal-article","created":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T10:06:28Z","timestamp":1675937188000},"page":"e068864","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Lower starting dose of roxadustat in non-dialysis-dependent chronic kidney disease patients with anaemia: a study protocol for a randomised, multicentre, open-label study"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5330-1040","authenticated-orcid":false,"given":"Ping","family":"Li","sequence":"first","affiliation":[{"name":"Department of Nephrology, First Medical Center of Chinese PLA General Hospital, Beijing, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2984-8905","authenticated-orcid":false,"given":"Xuefeng","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Nephrology, First Medical Center of Chinese PLA General Hospital, Beijing, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinghua","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nephrology, First Medical Center of Chinese PLA General Hospital, Beijing, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-li","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The First Affiliated Hospital of Dalian Medical University, Dalian, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, First Medical Center of Chinese PLA General Hospital, Beijing, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiqing","family":"Wu","sequence":"additional","affiliation":[{"name":"Medical Affairs & Biometrics department, FibroGen, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuting","family":"Pan","sequence":"additional","affiliation":[{"name":"Medical Affairs & Biometrics department, FibroGen, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8586-6353","authenticated-orcid":false,"given":"Guangyan","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Nephrology, First Medical Center of Chinese PLA General Hospital, Beijing, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangmei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nephrology, First Medical Center of Chinese PLA General Hospital, Beijing, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,2,9]]},"reference":[{"key":"2025121512470704000_13.2.e068864.1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084943","article-title":"Prevalence of anemia in chronic kidney disease in the United States","volume":"9","author":"Stauffer","year":"2014","journal-title":"PLoS One"},{"key":"2025121512470704000_13.2.e068864.2","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003872","article-title":"Prevalence, awareness, and treatment of anemia in Chinese patients with nondialysis chronic kidney disease: first multicenter, cross-sectional study","volume":"95","author":"Li","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2025121512470704000_13.2.e068864.3","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-022-02778-8","article-title":"Epidemiology and outcomes in patients with anemia of CKD not on dialysis from a large US healthcare system database: a retrospective observational study","volume":"23","author":"Lamerato","year":"2022","journal-title":"BMC Nephrol"},{"key":"2025121512470704000_13.2.e068864.4","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s41669-019-0132-5","article-title":"Economic burden and health-related quality of life associated with current treatments for anaemia in patients with CKD not on dialysis: a systematic review","volume":"3","author":"Pergola","year":"2019","journal-title":"Pharmacoecon Open"},{"key":"2025121512470704000_13.2.e068864.5","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.2000.88.4.1474"},{"key":"2025121512470704000_13.2.e068864.6","doi-asserted-by":"publisher","DOI":"10.4161\/cc.7.1.5145"},{"key":"2025121512470704000_13.2.e068864.7","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2015030241"},{"key":"2025121512470704000_13.2.e068864.8","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-01077-1"},{"key":"2025121512470704000_13.2.e068864.9","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.12892"},{"key":"2025121512470704000_13.2.e068864.10","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ajh.26397","article-title":"Roxadustat for the treatment of anemia in patients with lower-risk myelodysplastic syndrome: open-label, dose-selection, lead-in stage of a phase 3 study","volume":"97","author":"Henry","year":"2022","journal-title":"Am J Hematol"},{"key":"2025121512470704000_13.2.e068864.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1813599"},{"key":"2025121512470704000_13.2.e068864.12","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-019-00943-4"},{"key":"2025121512470704000_13.2.e068864.13","doi-asserted-by":"publisher","DOI":"10.1159\/000508100"},{"key":"2025121512470704000_13.2.e068864.14","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.06890615"},{"key":"2025121512470704000_13.2.e068864.15","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.16191020"},{"key":"2025121512470704000_13.2.e068864.16","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e7586","article-title":"Spirit 2013 explanation and elaboration: guidance for protocols of clinical trials","volume":"346","author":"Chan","year":"2013","journal-title":"BMJ"},{"key":"2025121512470704000_13.2.e068864.17","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/bcp.15055","article-title":"Efficacy and safety of roxadustat for anaemia in dialysis-dependent and non-dialysis-dependent chronic kidney disease patients: a systematic review and meta-analysis","volume":"88","author":"Zheng","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"2025121512470704000_13.2.e068864.18","first-page":"1603","article-title":"The efficacy and safety of roxadustat for anemia in patients with chronic kidney disease: a meta-analysis. nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association","volume":"36","author":"Zheng","year":"2021","journal-title":"European Renal Association"},{"key":"2025121512470704000_13.2.e068864.19","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2019060623"},{"key":"2025121512470704000_13.2.e068864.20","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/j.ekir.2021.04.007","article-title":"A randomized trial of roxadustat in anemia of kidney failure: SIERRAS study","volume":"6","author":"Charytan","year":"2021","journal-title":"Kidney Int Rep"},{"key":"2025121512470704000_13.2.e068864.21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1901713"},{"key":"2025121512470704000_13.2.e068864.22","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.ekir.2021.04.003","article-title":"Phase 3 study of roxadustat to treat anemia in non-dialysis-dependant CKD","volume":"6","author":"Akizawa","year":"2021","journal-title":"Kidney Int Rep"},{"key":"2025121512470704000_13.2.e068864.23","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/ndt\/gfab191","article-title":"Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: a phase 3, randomized, open-label, active-controlled study (DOLOMITES)","volume":"36","author":"Barratt","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"2025121512470704000_13.2.e068864.24","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ekir.2020.11.034","article-title":"Roxadustat for CKD-related anemia in non-dialysis patients","volume":"6","author":"Coyne","year":"2021","journal-title":"Kidney Int Rep"},{"key":"2025121512470704000_13.2.e068864.25","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1007\/s12325-021-01904-6","article-title":"Roxadustat for the maintenance treatment of anemia in patients with end-stage kidney disease on stable dialysis: a European phase 3, randomized, open-label, active-controlled study (Pyrenees)","volume":"38","author":"Csiky","year":"2021","journal-title":"Adv Ther"},{"key":"2025121512470704000_13.2.e068864.26","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2020081150"},{"key":"2025121512470704000_13.2.e068864.27","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2020111638"},{"key":"2025121512470704000_13.2.e068864.28","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jfma.2021.06.004","article-title":"Roxadustat treatment for anemia in peritoneal dialysis patients: a randomized controlled trial","volume":"121","author":"Hou","year":"2022","journal-title":"J Formos Med Assoc"},{"key":"2025121512470704000_13.2.e068864.29","first-page":"1717","article-title":"Roxadustat for anemia in patients with end-stage renal disease incident to dialysis. Nephrology, Dialysis, Transplantation: official publication of the European Dialysis and Transplant Association","volume":"36","author":"Provenzano","year":"2021","journal-title":"European Renal Association"},{"key":"2025121512470704000_13.2.e068864.30","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfab057"},{"key":"2025121512470704000_13.2.e068864.31","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfx011"},{"key":"2025121512470704000_13.2.e068864.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30045-3"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2022-068864","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T20:47:14Z","timestamp":1765831634000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2022-068864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":32,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2,9]]},"published-print":{"date-parts":[[2023,2]]}},"alternative-id":["10.1136\/bmjopen-2022-068864"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2022-068864","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2023,2]]}}}